IL28B: Relevance extended to hepatitis B virus or limited to interferon-based therapies in hepatitis C virus?

Liver International

Volumn 31, Issue 8, 2011, Pages 1068-1070

  Tillmann, Hans L ^a   Yu, Ming Whei ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; INTERFERON; INTERLEUKIN 28B; PEGINTERFERON; RIBAVIRIN; VIRUS DNA;

EDITORIAL; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; IMMUNOMODULATION; NONHUMAN; SEROCONVERSION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; VIRAL CLEARANCE; VIRUS LOAD; VIRUS REPLICATION;

ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKINS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79961207437     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02594.x     Document Type: Editorial

References (20)

1. Thio CL, Thomas DL. Interleukin-28b: a key piece of the hepatitis C virus recovery puzzle. Gastroenterology 2010; 138: 1240-3.
2. Lagging M, Askarieh G, Negro F, et al. Response prediction in chronic hepatitis C by assessment of the IP-10 and IL28B-related single nucleotide polymorphisms. PLoS one 2011; 6: e17232.
3. Ito K, Higami K, Masaki N, et al. The rs8099917 polymorphism, determined by a suitable genotyping method is a better predictor for response to pegylated interferon-alpha/ribavirin therapy in Japanese Patients than other SNPs associated with IL28B. J Clin Microbiol 2011; 49: 1853-60.
4. Rao HY, Sun DG, Jiang D. IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection. J Hepatol 2011; 54(Suppl. 1): S529.
5. Lin CY, Chen JY, Lin TN, et al. IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection. PLoS One 2011; 6: e18322.
6. Kamatani Y, Wattanapokayakit S, Ochi H, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009; 41: 591-5.
7. Martin MP, Qi Y, Goedert JJ, et al. IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection. J Infect Dis 2010; 202: 1749-53.
8. Li W, Jiang Y, Jin Q, et al. Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population. Liver Int 2011; 31: 1118-26.
9. Takkenberg B, de Niet A, Benayed R, et al. Association between treatment outcome and rs12979860 polymorphism in HBeAg positive and negative chronic hepatitis B patients treated with Peginterferon alfa-2a (Pegasys) and Adefovir (Hepsera); An interim analysis. Presented as late breaker at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2010). Boston, October 29-November 2, 2010. Available at (accessed 11 May 2011).
10. Lütgehetmann M, Bornscheuer T, Volz T, et al. Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice. Gastroenterology 2011; 140: 2074-83; e2.
11. Mangia A, Santoro R, Mottola L, et al. Lack of association between IL28B variants and HBsAg clearance after interferon Therapy. J Hepatol 2011; 54: S525.
12. Sonneveld MJ, Wong VWS, Woltman AM, et al. Polymorphisms at rs12979860 and rs12980275 near IL28B predict serological response to Peg-Interferon in HBeAg positive chronic hepatitis B. J Hepatol 2011; 54: S525.
13. Lampertico P, Vigano M, Cheroni C, et al. Genetic variation in IL28B polymorphism may predict HBsAg clearance in genotype D, HBeAg negative patients treated with interferon alfa. Hepatology 2010; 52: 442A.
14. Honda M, Sakai A, Yamashita T, et al. Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology 2010; 139: 499-509.
15. Shebl FM, Maeder D, Shao Y, et al. In the absence of HCV infection, interferon stimulated gene expression in liver is not associated with IL28B genotype. Gastroenterology 2010; 139: 1422-4.
16. Wu CF, Yu MW, Lin CL, et al. Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men. Carcinogenesis 2008; 29: 106-12.
17. Sung FY, Jung CM, Wu CF, et al. Hepatitis B virus core variants modify natural course of viral infection and hepatocellular carcinoma progression. Gastroenterology 2009; 137: 1687-97.
18. Yu ML, Chuang WL. Treatment of chronic hepatitis C in Asia: when East meets West. J Gastroenterol Hepatol 2009; 24: 336-45.
19. Mangia A, Thompson AJ, Santoro R, et al. An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response. Gastroenterology 2010; 139: 821-7.
20. Huang HH, Shih WL, Li YH, et al. Hepatitis B viraemia: its heritability and association with common genetic variation in the interferon gamma signaling pathway. Gut 2011; 60: 99-107.